1. Home
  2. IOVA vs MFA Comparison

IOVA vs MFA Comparison

Compare IOVA & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.60

Market Cap

881.3M

Sector

Health Care

ML Signal

HOLD

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

HOLD

Current Price

$9.56

Market Cap

976.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
MFA
Founded
2007
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
881.3M
976.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IOVA
MFA
Price
$2.60
$9.56
Analyst Decision
Buy
Buy
Analyst Count
12
7
Target Price
$10.45
$10.96
AVG Volume (30 Days)
12.8M
1.6M
Earning Date
02-26-2026
02-18-2026
Dividend Yield
N/A
14.94%
EPS Growth
N/A
N/A
EPS
N/A
0.86
Revenue
$250,425,000.00
$279,011,000.00
Revenue This Year
$60.71
N/A
Revenue Next Year
$59.52
N/A
P/E Ratio
N/A
$11.21
Revenue Growth
175.62
N/A
52 Week Low
$1.64
$7.85
52 Week High
$6.36
$11.08

Technical Indicators

Market Signals
Indicator
IOVA
MFA
Relative Strength Index (RSI) 51.15 44.26
Support Level $2.21 $9.81
Resistance Level $3.03 $10.19
Average True Range (ATR) 0.20 0.22
MACD 0.00 -0.03
Stochastic Oscillator 48.78 9.16

Price Performance

Historical Comparison
IOVA
MFA

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

Share on Social Networks: